Respiratory Morbidity Clinical Trial
Official title:
Effect of Single Dose Antenatal Betamethasone on the Incidence of Neonatal Respiratory Morbidity After Elective Cesarean Section at Term: A Prospective Double Blinded Placebo Controlled Trial
Patients undergoing elective C-section will be randomized into two groups. The first group will receive one dose of Betamethasone at least 24 hours before scheduled C-section. The second group will receive placebo.
This is a prospective double blinded randomized clinical trial. Patients will be randomized into two groups. Group A will receive one dose of Betamethasone at least 24 hours before scheduled C-section. Group B will receive placebo. The maternal and neonatal outcomes will be studied in order to assess the effect of Betamethasone on respiratory morbidity of the newborn infant. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02555605 -
Dexmedetomidine Sedation in Children With Respiratory Morbidities
|
N/A | |
| Enrolling by invitation |
NCT06188988 -
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
|
||
| Completed |
NCT03588689 -
Continuous Fascia Iliaca Block for Acute Hip Fractures
|
Phase 4 | |
| Completed |
NCT01759992 -
Effects and Costs of Respiratory Muscle Training in Institutionalized Elderly People
|
N/A | |
| Completed |
NCT04397991 -
Inhaled Furosemide for Transient Tachypnea of Newborn
|
N/A | |
| Recruiting |
NCT05698966 -
Low Dose Antenatal Corticosteroids for Late Preterm Delivery
|
N/A | |
| Completed |
NCT03165305 -
The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants
|
N/A |